The IMPT serves as the ‘communications and information hub’ for the field of multipurpose prevention technologies (MPTs).
Our resource center features a searchable database, providing you access to global MPT research, technical webinars, trainee and career resources, advocacy tools, and more. Search our resources!
Resource Search
Search Results
MPTs & the IMPT Platform
MPTs & the IMPT Platform May 2021 The MPTs & the IMPT Platform is a PowerPoint presentation created by the IMPT Secretariat at CAMI Health to help our colleagues integrate MPTs into their talks and presentations. Please email IMPT@cami-health.org with any feedback on how you used this information. Download the presentation slide deck CAMI Health […]
Multipurpose Prevention Technologies (MPTs): a promising response to current challenges around hormonal contraceptive methods & HIV – Power Point
Multipurpose Prevention Technologies (MPTs): a promising response to current challenges around hormonal contraceptive methods & HIV – Power Point 27 January 2016 click to view Presentation In this Presentation: Health Risk(s): HIV STI / STD Unintended Pregnancy Product Type(s): MPTs Topic(s): Education MPTs Region(s): Global
New Developments in Barrier Contraception: Implications for Multipurpose Prevention Technologies (MPTs)
New Developments in Barrier Contraception: Implications for Multipurpose Prevention Technologies (MPTs) 14 November 2015 Panel session at the 2015 North American Forum on Family Planning in Chicago, IL This panel presented on the promising application of new contraceptive barrier methods in MPT development, and provided an outline of the MPT field as a whole. Presenters: […]
Multipurpose Prevention Technologies (MPTs): New reproductive health products on the horizon
Multipurpose Prevention Technologies (MPTs): New reproductive health products on the horizon 07 October 2015 Panel session during the New and Underused Reproductive Health Technologies (NURHT) Caucus at the 2015 Reproductive Health Supplies Coalition (RHSC) General Membership Meeting, in Oslo, Norway The session provided an overview of the MPT product development pipeline, and addressed key questions […]
Multipurpose Prevention Technologies (MPTs): Developing interventions to simultaneously prevent STIs, HIV and Pregnancy – Presentation
Multipurpose Prevention Technologies (MPTs): Developing interventions to simultaneously prevent STIs, HIV and Pregnancy – Presentation 16 September 2015 Panel session at the 2015 ISSTDR World STI & HIV Congress in Brisbane, Australia Co-sponsored by the World Health Organization (WHO), the University of California San Francisco (UCSF) Bixby Center, the Initiative for MPTs (IMPT), and the […]
MPTs: What Are they, and Why Are they Needed?
MPTs: What Are they, and Why Are they Needed? October 2014 click to view Presentation In this Presentation: Health Risk(s): HIV STI / STD Unintended Pregnancy Product Type(s): MPTs Topic(s): Advocacy Product Development Risk
State of the Art: Multipurpose Prevention Technology Science and Product Development
State of the Art: Multipurpose Prevention Technology Science and Product Development October 2014 click to view Presentation In this Presentation: Health Risk(s): HIV STI / STD Unintended Pregnancy Product Type(s): MPTs Topic(s): Product Development
Regulatory Considerations with Developing Combination Products
Regulatory Considerations with Developing Combination Products October 2014 click to view Presentation In this Presentation: Health Risk(s): HIV STI / STD Product Type(s): MPTs Topic(s): Product Development Regulatory Issues
Study Designs for Evaluating the Effectiveness of Multipurpose Technologies
Study Designs for Evaluating the Effectiveness of Multipurpose Technologies October 2014 click to view Presentation In this Presentation: Health Risk(s): HIV STI / STD Unintended Pregnancy Product Type(s): MPTs Topic(s): Product Development Product Trials
Multipurpose Prevention Technologies
Multipurpose Prevention Technologies October 2014 click to view Presentation In this Presentation: Health Risk(s): HIV STI / STD Unintended Pregnancy Product Type(s): MPTs Topic(s): Epidemiology Social/Behavioral Context
Round Table Discussion: Multipurpose Prevention Technologies
Round Table Discussion: Multipurpose Prevention Technologies October 2014 click to view Presentation In this Presentation: Health Risk(s): HIV STI / STD Unintended Pregnancy Product Type(s): MPTs Topic(s): Product Development Risk Social/Behavioral Context
Multipurpose Prevention Technologies: Impact Investing for Global Reproductive Health
Multipurpose Prevention Technologies: Impact Investing for Global Reproductive Health 05 September 2014 click to view Presentation In this Presentation: Health Risk(s): HIV STI / STD Unintended Pregnancy Product Type(s): MPTs Topic(s): Collective Impact MPTs Product Development Risk
Women’s Health in Women’s Hands: The Promise of MPTs
Women’s Health in Women’s Hands: The Promise of MPTs 02 July 2014 The Stewart Center West at UCSF ANSIRH Oakland, CA CAMI hosted a panel and reception featuring Manjula Lusti-Narasimhan (WHO), Ina Park (CDPH/UCSF), Bethany Young Holt (CAMI/PHI) and others to discuss innovative prevention strategies that can simultaneously address risk for unintended pregnancies and STIs, […]
Indian women’s perceptions of vaginal rings-feedback for development of multipurpose prevention technologies
Indian women’s perceptions of vaginal rings-feedback for development of multipurpose prevention technologies November 2013 click to view Presentation In this Presentation: Health Risk(s): HIV STI / STD Unintended Pregnancy Product Type(s): IVR (Intravaginal Rings) MPTs Topic(s): Product Development Product Trials Social/Behavioral Context
Supporting Agency Coordination and Cooperation in the Development of Contraceptive Methods Appropriate for Provision and Use in Low Resource Settings
Supporting Agency Coordination and Cooperation in the Development of Contraceptive Methods Appropriate for Provision and Use in Low Resource Settings November 2013 click to view Presentation In this Presentation: Health Risk(s): HIV STI / STD Unintended Pregnancy Product Type(s): Contraceptives Topic(s): Product Development
Introducing Novel Technologies at the Country Level; Promoting Approval, Access and Acceptance
Introducing Novel Technologies at the Country Level; Promoting Approval, Access and Acceptance November 2013 click to view Presentation In this Presentation: Health Risk(s): HIV STI / STD Unintended Pregnancy Product Type(s): Contraceptives Topic(s): Social/Behavioral Context SRH Linkages
The Development of Two Multipurpose Prevention Technology (MPT) Products, the Regulatory Pathway for Each, and the Initiation of Clinical Studies
The Development of Two Multipurpose Prevention Technology (MPT) Products, the Regulatory Pathway for Each, and the Initiation of Clinical Studies November 2013 click to view Presentation In this Presentation: Health Risk(s): HIV STI / STD Unintended Pregnancy Product Type(s): MPTs Topic(s): Product Development Product Trials Regulatory Issues
MPTs: Assessing Acceptability and Adherence
MPTs: Assessing Acceptability and Adherence November 2013 click to view Presentation In this Presentation: Health Risk(s): HIV STI / STD Unintended Pregnancy Product Type(s): MPTs Topic(s): Product Development Social/Behavioral Context
SILCS in South Africa: Opportunities for introduction as a barrier contraceptive and as an MPT
SILCS in South Africa: Opportunities for introduction as a barrier contraceptive and as an MPT November 2013 click to view Presentation In this Presentation: Health Risk(s): HIV STI / STD Unintended Pregnancy Product Type(s): Diaphragm MPTs Topic(s): Product Development Product Trials
Regional Priorities for Multipurpose Prevention Technologies: the Epidemiological and Demographic Data
Regional Priorities for Multipurpose Prevention Technologies: the Epidemiological and Demographic Data November 2013 click to view Presentation In this Presentation: Health Risk(s): HIV STI / STD Unintended Pregnancy Product Type(s): MPTs Topic(s): Epidemiology Product Development
The Reality on the Ground: What Users and Providers Want and Need in MPTs
The Reality on the Ground: What Users and Providers Want and Need in MPTs November 2013 click to view Presentation In this Presentation: Health Risk(s): HIV STI / STD Unintended Pregnancy Product Type(s): MPTs Topic(s): Product Development Social/Behavioral Context
Multipurpose Prevention Technologies (MPTs) for Sexual and Reproductive Health
Multipurpose Prevention Technologies (MPTs) for Sexual and Reproductive Health September 2013 click to view Presentation In this Presentation: Health Risk(s): HIV STI / STD Unintended Pregnancy Product Type(s): MPTs Topic(s): Education Product Development
Multipurpose Prevention Technologies (MPTs) for Girls and Women: Introduction
Multipurpose Prevention Technologies (MPTs) for Girls and Women: Introduction 30 May 2013 click to view Presentation In this Presentation: Health Risk(s): HIV STI / STD Unintended Pregnancy Product Type(s): MPTs Topic(s): Education Product Development
What are MPTs and why do we need them? What’s available now and on the horizon – Chandhiok
What are MPTs and why do we need them? What’s available now and on the horizon – Chandhiok 30 May 2013 click to view Presentation In this Presentation: Health Risk(s): HIV STI / STD Unintended Pregnancy Product Type(s): MPTs Topic(s): Education Product Development
Microbicides, where are we today?
Microbicides, where are we today? 30 May 2013 click to view Presentation In this Presentation: Health Risk(s): HIV STI / STD Unintended Pregnancy Product Type(s): Microbicides MPTs Topic(s): Product Development Product Trials
Aligning investments in MPT Research & Development
Aligning investments in MPT Research & Development May 2013 click to view Presentation In this Presentation: Health Risk(s): HIV STI / STD Unintended Pregnancy Product Type(s): MPTs Topic(s): Product Development
What do these technologies mean for women living with HIV?
What do these technologies mean for women living with HIV? May 2013 click to view Presentation In this Presentation: Health Risk(s): HIV STI / STD Unintended Pregnancy Product Type(s): MPTs Topic(s): Social/Behavioral Context
What are MPTs and why do we need them? What’s available now and on the horizon – Rees
What are MPTs and why do we need them? What’s available now and on the horizon – Rees May 2013 click to view Presentation In this Presentation: Health Risk(s): HIV STI / STD Unintended Pregnancy Product Type(s): MPTs Topic(s): Epidemiology Product Development
MPTs available now and on the horizon
MPTs available now and on the horizon May 2013 click to view Presentation In this Presentation: Health Risk(s): HIV STI / STD Unintended Pregnancy Product Type(s): MPTs Topic(s): Product Development
Aligning investments in MPT R&D and the critical path to MPT introduction
Aligning investments in MPT R&D and the critical path to MPT introduction May 2013 click to view Presentation In this Presentation: Health Risk(s): HIV STI / STD Unintended Pregnancy Product Type(s): MPTs Topic(s): Product Development
HIV Prevention and MPT Product Pipeline Update
HIV Prevention and MPT Product Pipeline Update 03 April 2013 click to view Presentation In this Presentation: Health Risk(s): HIV Unintended Pregnancy Product Type(s): MPTs Topic(s): Product Development
A Critical Look Down the Critical Path to MPT Development
A Critical Look Down the Critical Path to MPT Development 20-21 February 2013 Washington, DC, USA click to view Presentation In this Presentation: Health Risk(s): General SRH Product Type(s): MPTs Topic(s): Regulatory Issues Region(s): Global Working Group(s): Other
The Need for MPTs: Overview of epidemiological trends and rationale for MPTs
The Need for MPTs: Overview of epidemiological trends and rationale for MPTs December 2012 click to view Presentation In this Presentation: Health Risk(s): HIV STI / STD Unintended Pregnancy Product Type(s): MPTs Topic(s): Advocacy Epidemiology Policy Product Development
Availability and Access of MPTs: Implementation Issues
Availability and Access of MPTs: Implementation Issues December 2012 click to view Presentation In this Presentation: Health Risk(s): HIV STI / STD Unintended Pregnancy Product Type(s): MPTs Topic(s): Product Introduction / Uptake
What Have We Learned From Other Reproductive Health Technologies?
What Have We Learned From Other Reproductive Health Technologies? December 2012 click to view Presentation In this Presentation: Health Risk(s): HIV STI / STD Unintended Pregnancy Product Type(s): ARVs Contraceptives MPTs Topic(s): Advocacy Policy Product Development Regulatory Issues Social/Behavioral Context
Availability & Access of MPTs: Implementation Issues Innovative partnerships/business models
Availability & Access of MPTs: Implementation Issues Innovative partnerships/business models December 2012 click to view Presentation In this Presentation: Health Risk(s): HIV STI / STD Unintended Pregnancy Product Type(s): MPTs Topic(s): Product Introduction / Uptake Public-Private Partnerships
Potential for increasing use of barrier methods in India
Potential for increasing use of barrier methods in India December 2012 click to view Presentation In this Presentation: Health Risk(s): HIV STI / STD Unintended Pregnancy Product Type(s): Condoms Topic(s): Reproductive Health
From Ideal to Real: The MPT R&D Pipeline
From Ideal to Real: The MPT R&D Pipeline December 2012 click to view Presentation In this Presentation: Health Risk(s): HIV STI / STD Unintended Pregnancy Product Type(s): MPTs Topic(s): Product Development Product Trials
BioRings Vaginal Ring
BioRings Vaginal Ring December 2012 click to view Presentation In this Presentation: Health Risk(s): HIV STI / STD Unintended Pregnancy Product Type(s): IVR (Intravaginal Rings) MPTs Topic(s): Product Development Product Trials
Review of MPTs in the Product Development Pipeline – Indian Perspective
Review of MPTs in the Product Development Pipeline – Indian Perspective December 2012 click to view Presentation In this Presentation: Health Risk(s): HIV STI / STD Unintended Pregnancy Product Type(s): MPTs Topic(s): Product Development Product Trials
The Effect of Intervaginal Basant in Patients with Cervical Intraepithelical Neoplasma and HPV DNA
The Effect of Intervaginal Basant in Patients with Cervical Intraepithelical Neoplasma and HPV DNA December 2012 click to view Presentation In this Presentation: Health Risk(s): HIV Other Product Type(s): Microbicides Topic(s): Product Trials
Communication Tools to Advance Support for Multipurpose Prevention Technologies (MPTs) in India Using a Messaging Framework to Coordinate Advocacy of MPTs
Communication Tools to Advance Support for Multipurpose Prevention Technologies (MPTs) in India Using a Messaging Framework to Coordinate Advocacy of MPTs December 2012 click to view Presentation In this Presentation: Health Risk(s): HIV STI / STD Unintended Pregnancy Product Type(s): MPTs Topic(s): Advocacy
Identification of Key Attributes and Prioritization of Product Development
Identification of Key Attributes and Prioritization of Product Development December 2012 click to view Presentation In this Presentation: Health Risk(s): HIV STI / STD Unintended Pregnancy Product Type(s): MPTs Topic(s): Product Development
Prioritising MPT Product – A Few Reflections
Prioritising MPT Product – A Few Reflections December 2012 click to view Presentation In this Presentation: Health Risk(s): HIV STI / STD Unintended Pregnancy Product Type(s): MPTs Topic(s): Product Development
Challenges in MPT research: limitations, gaps and opportunities
Challenges in MPT research: limitations, gaps and opportunities December 2012 click to view Presentation In this Presentation: Health Risk(s): HIV STI / STD Unintended Pregnancy Product Type(s): MPTs Topic(s): Product Development Product Trials
Meeting objectives: Symposium on accelerating research on MPTs
Meeting objectives: Symposium on accelerating research on MPTs December 2012 click to view Presentation In this Presentation: Health Risk(s): HIV STI / STD Unintended Pregnancy Product Type(s): MPTs Topic(s): Education
Considerations for the Regulatory Approval of Multipurpose Prevention Technologies (MPTs)
Considerations for the Regulatory Approval of Multipurpose Prevention Technologies (MPTs) December 2012 click to view Presentation In this Presentation: Health Risk(s): HIV STI / STD Unintended Pregnancy Product Type(s): MPTs Topic(s): Product Development Regulatory Issues